Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kromer

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|August 14, 2019
Marginal zone lymphoma presenting as macrocheiliaC Kromer, A Bleckmann, M P Schön, et al.
The Journal of Dermatological Treatment|February 4, 2020
Changing within the same class: efficacy of brodalumab in plaque psoriasis after treatment with an IL-17A blocker - a retrospective multicenter studyC Kromer, D Wilsmann-Theis, S Gerdes, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 26, 2021
The challenge of palmoplantar pustulosis therapy: Are Interleukin-23 inhibitors an option?S Poortinga, G Balakirski, C Kromer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 2, 2021
A multicentre open-label study of apremilast in palmoplantar pustulosis (APLANTUS)D Wilsmann-Theis, C Kromer, S Gerdes, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of the European Academy of Dermatology and Venereology : JEADV|August 14, 2019
Marginal zone lymphoma presenting as macrocheiliaC Kromer, A Bleckmann, M P Schön, et al.
The Journal of Dermatological Treatment|February 4, 2020
Changing within the same class: efficacy of brodalumab in plaque psoriasis after treatment with an IL-17A blocker - a retrospective multicenter studyC Kromer, D Wilsmann-Theis, S Gerdes, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 26, 2021
The challenge of palmoplantar pustulosis therapy: Are Interleukin-23 inhibitors an option?S Poortinga, G Balakirski, C Kromer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 2, 2021
A multicentre open-label study of apremilast in palmoplantar pustulosis (APLANTUS)D Wilsmann-Theis, C Kromer, S Gerdes, et al.
Pageof 1